Skip to Content
Skip to Navigation

Browse Faculty by
Last Name

Access your account with your UWNetID

Bruce M. Psaty, MD, PhD, MPH

Professor, Department of Medicine (DOM)
Professor (joint), Epidemiology
Adjunct Professor, Department of Health Services
Co-director, Cardiovascular Health Research Unit
Senior Investigator, Group Health Research Institute

Education & Training

PhD, English language and literature, Indiana University, Bloomington, IN, 1979
MD, Indiana University, School of Medicine, Indianapolis, IN, 1981
Residency in Internal Medicine, Indiana University Medical Center, Indianapolis, IN, 1984
MPH, Epidemiology, University of Washington, Seattle, WA, 1986

Professional Interests

Myocardial infarction, venous thrombosis, and stroke
Hypertension, hyperlipidemia, diabetes, and atrial fibrillation
Genetics, Genomics, and pharmacogenetics
Epidemiologic methods


Remington Methodology Lecturer, AHA Epidemiology and Prevention Council, 2004
School of Public Health and Community Medicine Outstanding Faculty Community Service Award, 2005
University of Washington Outstanding Public Service Award for work in drug safety, 2005
Ancel Keys Memorial Lectureship, American Heart Association National Meeting, 2009
Member, US Food and Drug Administration Science Board, 2011-
Member, National Heart, Lung, Blood Institute Advisory Council, 2012-
Designated Distinguished Scientist by the American Heart Association, 2013
Elected to the Institute of Medicine of the National Academies of Science, 2013

Selected Publications

Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, Rosendaal FR, Lemaitre RN, Smith NL, Wahl PW, Wagner EH, Furberg CD. The risk of myocardial infarction associated with anti-hypertensive drug therapies. JAMA 1995; 274: 620-625.
Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534-2544.
Psaty BM, Kronmal RA. Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA. 2008 Apr 16;299(15):1813-7.
Psaty BM, O’Donnell CJ, Gudnason V, Kunetta KL, Folsom AR, Rotter JI, Uitterlinden AG, Harris TB, Witteman JCM, Boerwinkle E on behalf of the CHARGE Consortiu. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet 2009; 2: 73-80.
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, … Psaty BM#, Abecasis GR#, Chakravarti A#, Elliott P#, van Duijn CM#, Newton-Cheh C#, Levy D#, Caulfield MJ#, Johnson T#. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011 Sep 11;478(7367):103-9. #These authors contributed equally.